HCPCS Level IIdrugActive
J7686
Treprostinil, non-comp unit
BETOS: D1G
Effective: 2011-01-01
Referenced in 4 policies
Description
Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tyvaso
Manufacturer
United Therapeutics Corporation
HCPCS Dosage
1.74 MG
Billing Units
1.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.